Date: 21-Aug-2019

Temasek, TrueNorth-CPPIB seek to invest in Biocon Biologics

Mumbai/New Delhi: Singaporeís investment company Temasek and homegrown private equity fund True North along with Canadian Pension Plan Investment Board (CPPIB) are separately in discussions to invest $300 million in Biocon Biologics India Ltd (BBIL) for a minority stake, said people aware of the matter. The company is a wholly owned subsidiary of Biocon Ltd.